Heterotrimeric G protein signaling via GIV/Girdin: Breaking the rules of engagement, space, and time

BioEssays

Volumn 38, Issue 4, 2016, Pages 379-393

  Aznar, Nicolas ^a   Kalogriopoulos, Nicholas ^a   Midde, Krishna K ^a   Ghosh, Pradipta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autophagy; cdk5: Girdin; Golgi; Growth factor receptor tyrosine kinases; Heterotrimeric G proteins

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; INITIATION FACTOR; PROTEIN GIRDIN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CCDC88A PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL JUNCTION; CELL POLARITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GOLGI COMPLEX; HUMAN; NONHUMAN; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TRANSACTIVATION; CARDIOVASCULAR DISEASES; CELL MEMBRANE; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; INTRACELLULAR MEMBRANE; METABOLISM; MOLECULAR MODEL; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY; PROTEIN ANALYSIS; TIME FACTOR;

CARDIOVASCULAR DISEASES; CELL MEMBRANE; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; INTRACELLULAR MEMBRANES; MICROFILAMENT PROTEINS; MODELS, MOLECULAR; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEIN INTERACTION MAPPING; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TIME FACTORS; VESICULAR TRANSPORT PROTEINS;

EID: 84975705905     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201500133     Document Type: Article

References (127)

1. Gilman AG. 1987. G proteins: transducers of receptor-generated signals. Annu Rev Biochem 56: 615-49.
2. Morris AJ, Malbon CC. 1999. Physiological regulation of G protein-linked signaling. Physiol Rev 79: 1373-430.
3. Lohse MJ, Hein P, Hoffmann C, Nikolaev VO, et al. 2008. Kinetics of G-protein-coupled receptor signals in intact cells. Br J Pharmacol 153: S125-32.
4. Hopkins AL, Groom CR. 2002. The druggable genome. Nat Rev Drug Discov 1: 727-30.
5. Sato M, Blumer JB, Simon V, Lanier SM. 2006. Accessory proteins for G proteins: partners in signaling. Annu Rev Pharmacol Toxicol 46: 151-87.
6. Siderovski DP, Willard FS. 2005. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int J Biol Sci 1: 51-66.
7. Ross EM, Wilkie TM. 2000. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69: 795-827.
8. Blumer JB, Oner SS, Lanier SM. 2012. Group II activators of G-protein signalling and proteins containing a G-protein regulatory motif. Acta Physiol (Oxf) 204: 202-18.
9. De Vries L, Zheng B, Fischer T, Elenko E, et al. 2000. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 40: 235-71.
10. Kimple RJ, Kimple ME, Betts L, Sondek J, et al. 2002. Structural determinants for GoLoco-induced inhibition of nucleotide release by Galpha subunits. Nature 416: 878-81.
11. Peterson YK, Hazard S, 3rd, Graber SG, Lanier SM. 2002. Identification of structural features in the G-protein regulatory motif required for regulation of heterotrimeric G-proteins. J Biol Chem 277: 6767-70.
12. De Vries L, Mousli M, Wurmser A, Farquhar MG. 1995. GAIP, a protein that specifically interacts with the trimeric G protein G alpha i3, is a member of a protein family with a highly conserved core domain. Proc Natl Acad Sci USA 92: 11916-20.
13. Druey KM, Blumer KJ, Kang VH, Kehrl JH. 1996. Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 379: 742-6.
14. Srinivasa SP, Watson N, Overton MC, Blumer KJ. 1998. Mechanism of RGS4, a GTPase-activating protein for G protein alpha subunits. J Biol Chem 273: 1529-33.
15. Berman DM, Wilkie TM, Gilman AG. 1996. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86: 445-52.
16. Blazer LL, Roman DL, Chung A, Larsen MJ, et al. 2011. Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins. Mol Pharmacol 78: 524-33.
17. Kimple AJ, Yasgar A, Hughes M, Jadhav A, et al. 2008. A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interaction. Comb Chem High Throughput Screen 11: 396-409.
18. Cismowski MJ, Ma C, Ribas C, Xie X, et al. 2000. Activation of heterotrimeric G-protein signaling by a ras-related protein. Implications for signal integration. J Biol Chem 275: 23421-4.
19. Tall GG, Krumins AM, Gilman AG. 2003. Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. J Biol Chem 278: 8356-62.
20. Chan P, Gabay M, Wright FA, Tall GG. 2011. Ric-8B is a GTP-dependent G protein alphas guanine nucleotide exchange factor. J Biol Chem 286: 19932-42.
21. Lee MJ, Dohlman HG. 2008. Coactivation of G protein signaling by cell-surface receptors and an intracellular exchange factor. Curr Biol 18: 211-5.
22. Natochin M, Campbell TN, Barren B, Miller LC, et al. 2005. Characterization of the G alpha(s) regulator cysteine string protein. J Biol Chem 280: 30236-41.
23. Vaidyanathan G, Cismowski MJ, Wang G, Vincent TS, et al. 2004. The Ras-related protein AGS1/RASD1 suppresses cell growth. Oncogene 23: 5858-63.
24. Tonissoo T, Lulla S, Meier R, Saare M, et al. 2012. Nucleotide exchange factor RIC-8 is indispensable in mammalian early development. Dev Dyn 239: 3404-15.
25. Garcia-Marcos M, Ghosh P, Farquhar MG. 2009. GIV is a nonreceptor GEF for G alpha i with a unique motif that regulates Akt signaling. Proc Natl Acad Sci USA 106: 3178-83.
26. Garcia-Marcos M, Ear J, Farquhar MG, Ghosh P. 2011. A GDI (AGS3) and a GEF (GIV) regulate autophagy by balancing G protein activity and growth factor signals. Mol Biol Cell 22: 673-86.
27. Garcia-Marcos M, Ghosh P, Ear J, Farquhar MG. 2010. A structural determinant that renders G alpha(i) sensitive to activation by GIV/girdin is required to promote cell migration. J Biol Chem 285: 12765-77.
28. Garcia-Marcos M, Kietrsunthorn PS, Pavlova Y, Adia MA, et al. 2012. Functional characterization of the guanine nucleotide exchange factor (GEF) motif of GIV protein reveals a threshold effect in signaling. Proc Natl Acad Sci USA 109: 1961-6.
29. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, et al. 2011. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 477: 549-55.
30. Coleman DE, Berghuis AM, Lee E, Linder ME, et al. 1994. Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. Science 265: 1405-12.
31. Leyme A, Marivin A, Perez-Gutierrez L, Nguyen LT, et al. 2015. Integrins activate trimeric G proteins via the non-receptor protein GIV/ Girdin. J Cell Biol 210: 1165-84.
32. Bhandari D, Lopez-Sanchez I, To A, Lo IC, et al. 2015. Cyclin-dependent kinase 5 activates guanine nucleotide exchange factor GIV/Girdin to orchestrate migration-proliferation dichotomy. Proc Natl Acad Sci USA 112: E4874-83.
33. Beas AO, Taupin V, Teodorof C, Nguyen LT, et al. 2012. Galphas promotes EEA1 endosome maturation and shuts down proliferative signaling through interaction with GIV (Girdin). Mol Biol Cell 23: 4623-34.
34. Ghosh P. 2015. Heterotrimeric G proteins as emerging targets for network based therapy in cancer: end of a long futile campaign striking heads of a Hydra. Aging 7: 469-74.
35. Ghosh P. 2015. G protein-coupled growth factor receptor tyrosine kinases: no longer an oxymoron. Cell Cycle 14: 2561-5.
36. Lopez-Sanchez I, Garcia-Marcos M, Mittal Y, Aznar N, et al. 2013. Protein kinase C-theta (PKCtheta) phosphorylates and inhibits the guanine exchange factor, GIV/Girdin. Proc Natl Acad Sci USA 110: 5510-5.
37. Ghosh P, Garcia-Marcos M, Farquhar MG. 2011. GIV/Girdin is a rheostat that fine-tunes growth factor signals during tumor progression. Cell Adh Migr 5: 237-48.
38. Ghosh P, Beas AO, Bornheimer SJ, Garcia-Marcos M, et al. 2010. A Gi-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell 21: 2338-54.
39. Schlessinger J. 2014. Receptor tyrosine kinases: legacy of the first two decades. Cold Spring Harb Perspect Biol 6: a008912.
40. Marty C, Ye RD. 2010. Heterotrimeric G protein signaling outside the realm of seven transmembrane domain receptors. Mol Pharmacol 78: 12-8.
41. Lin C, Ear J, Midde K, Lopez-Sanchez I, et al. 2014. Structural basis for activation of trimeric Gi proteins by multiple growth factor receptors via GIV/Girdin. Mol Biol Cell 25: 3654-71.
42. Malaney P, Uversky VN, Dave V. 2015. Identification of intrinsically disordered regions in PTEN and delineation of its function via a network approach. Methods 77-78: 69-74.
43. Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, et al. 2002. Intrinsic disorder and protein function. Biochemistry 41: 6573-82.
44. Dunker AK, Uversky VN. 2008. Signal transduction via unstructured protein conduits. Nat Chem Biol 4: 229-30.
45. Dyson HJ, Wright PE. 2002. Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol 12: 54-60.
46. Dyson HJ, Wright PE. 2005. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6: 197-208.
47. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z, et al. 2002. Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 323: 573-84.
48. Malaney P, Uversky VN, Dave V. 2013. The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy. Mol Biosyst 9: 2877-88.
49. Malaney P, Pathak RR, Xue B, Uversky VN, et al. 2013. Intrinsic disorder in PTEN and its interactome confers structural plasticity and functional versatility. Sci Rep 3: 2035.
50. Lohse MJ, Hoffmann C, Nikolaev VO, Vilardaga JP, et al. 2007. Kinetic analysis of G protein-coupled receptor signaling using fluorescence resonance energy transfer in living cells. Adv Protein Chem 74: 167-88.
51. Ross EM. 2008. Coordinating speed and amplitude in G-protein signaling. Curr Biol 18: R777-83.
52. Midde KK, Aznar N, Laederich MB, Ma GS, et al. 2015. Multimodular biosensors reveal a novel platform for activation of G proteins by growth factor receptors. Proc Natl Acad Sci USA 112: E937-46.
53. Sorkin A, McClure M, Huang F, Carter R. 2000. Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr Biol 10: 1395-8.
54. Lee HY, Jung H, Jang IH, Suh PG, et al. 2008. Cdk5 phosphorylates PLD2 to mediate EGF-dependent insulin secretion. Cell Signal 20: 1787-94.
55. Gibson SK, Gilman AG. 2006. Gialpha and Gbeta subunits both define selectivity of G protein activation by alpha2-adrenergic receptors. Proc Natl Acad Sci USA 103: 212-7.
56. Bunemann M, Frank M, Lohse MJ. 2003. Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc Natl Acad Sci USA 100: 16077-82.
57. Janetopoulos C, Jin T, Devreotes P. 2001. Receptor-mediated activation of heterotrimeric G-proteins in living cells. Science 291: 2408-11.
58. Yi TM, Kitano H, Simon MI. 2003. A quantitative characterization of the yeast heterotrimeric G protein cycle. Proc Natl Acad Sci USA 100: 10764-9.
59. Ponsioen B, Zhao J, Riedl J, Zwartkruis F, et al. 2004. Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep 5: 1176-80.
60. Irannejad R, Tomshine JC, Tomshine JR, Chevalier M, et al. 2013. Conformational biosensors reveal GPCR signalling from endosomes. Nature 495: 534-8.
61. Lo IC, Gupta V, Midde KK, Taupin V, et al. 2015. Activation of Galphai at the Golgi by GIV/Girdin imposes finiteness in Arf1 signaling. Dev Cell 33: 189-203.
62. Sasaki K, Kakuwa T, Akimoto K, Koga H, et al. 2015. Regulation of epithelial cell polarity by PAR-3 depends on Girdin transcription and Girdin-Galphai3 signaling. J Cell Sci 128: 2244-58.
63. Lum JJ, DeBerardinis RJ, Thompson CB. 2005. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 6: 439-48.
64. Beugnet A, Tee AR, Taylor PM, Proud CG. 2003. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. Biochem J 372: 555-66.
65. Meijer AJ, Codogno P. 2004. Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 36: 2445-62.
66. Gohla A, Klement K, Piekorz RP, Pexa K, et al. 2007. An obligatory requirement for the heterotrimeric G protein Gi3 in the antiautophagic action of insulin in the liver. Proc Natl Acad Sci USA 104: 3003-8.
67. Ogier-Denis E, Couvineau A, Maoret JJ, Houri JJ, et al. 1995. A heterotrimeric Gi3-protein controls autophagic sequestration in the human colon cancer cell line HT-29. J Biol Chem 270: 13-6.
68. Ogier-Denis E, Houri JJ, Bauvy C, Codogno P. 1996. Guanine nucleotide exchange on heterotrimeric Gi3 protein controls autophagic sequestration in HT-29 cells. J Biol Chem 271: 28593-600.
69. Ogier-Denis E, Pattingre S, El Benna J, Codogno P. 2000. Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. J Biol Chem 275: 39090-5.
70. Pattingre S, De Vries L, Bauvy C, Chantret I, et al. 2003. The G-protein regulator AGS3 controls an early event during macroautophagy in human intestinal HT-29 cells. J Biol Chem 278: 20995-1002.
71. Ogier-Denis E, Petiot A, Bauvy C, Codogno P. 1997. Control of the expression and activity of the Galpha-interacting protein (GAIP) in human intestinal cells. J Biol Chem 272: 24599-603.
72. Cao C, Huang X, Han Y, Wan Y, et al. 2009. Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Sci Signal 2: ra17.
73. Stow JL, de Almeida JB, Narula N, Holtzman EJ, et al. 1991. A heterotrimeric G protein, G alpha i-3, on Golgi membranes regulates the secretion of a heparan sulfate proteoglycan in LLC-PK1 epithelial cells. J Cell Biol 114: 1113-24.
74. Barr FA, Leyte A, Huttner WB. 1992. Trimeric G proteins and vesicle formation. Trends Cell Biol 2: 91-4.
75. Chisari M, Saini DK, Kalyanaraman V, Gautam N. 2007. Shuttling of G protein subunits between the plasma membrane and intracellular membranes. J Biol Chem 282: 24092-8.
76. Tsutsumi R, Fukata Y, Noritake J, Iwanaga T, et al. 2009. Identification of G protein alpha subunit-palmitoylating enzyme. Mol Cell Biol 29: 435-47.
77. Giannotta M, Ruggiero C, Grossi M, Cancino J, et al. 2012. The KDEL receptor couples to Galphaq/11 to activate Src kinases and regulate transport through the Golgi. EMBO J 31: 2869-81.
78. Colombo MI, Inglese J, D'Souza-Schorey C, Beron W, et al. 1995. Heterotrimeric G proteins interact with the small GTPase ARF. Possibilities for the regulation of vesicular traffic. J Biol Chem 270: 24564-71.
79. Cohen LA, Donaldson JG. 2010. Analysis of Arf GTP-binding protein function in cells. Curr Protoc Cell Biol Chapter 3: Unit 14.12. 1-7.
80. Shiba Y, Kametaka S, Waguri S, Presley JF, et al. 2013. ArfGAP3 regulates the transport of cation-independent mannose 6-phosphate receptor in the post-Golgi compartment. Curr Biol 23: 1945-51.
81. Kaplan NA, Liu X, Tolwinski NS. 2009. Epithelial polarity: interactions between junctions and apical-basal machinery. Genetics 183: 897-904.
82. Martin-Belmonte F, Perez-Moreno M. 2012. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 12: 23-38.
83. Ohara K, Enomoto A, Kato T, Hashimoto T, et al. 2012. Involvement of Girdin in the determination of cell polarity during cell migration. PLoS ONE 7: e36681.
84. Houssin E, Tepass U, Laprise P. 2015. Girdin-mediated interactions between cadherin and the actin cytoskeleton are required for epithelial morphogenesis in Drosophila. Development 142: 1777-84.
85. Ichimiya H, Maeda K, Enomoto A, Weng L, et al. 2015. Girdin/GIV regulates transendothelial permeability by controlling VE-cadherin trafficking through the small GTPase, R-Ras. Biochem Biophys Res Commun 461: 260-7.
86. Garcia-Marcos M, Ghosh P, Farquhar MG. 2015. GIV/Girdin transmits signals from multiple receptors by triggering trimeric G protein activation. J Biol Chem 290: 6697-704.
87. Ma GS, Aznar N, Kalogriopoulos N, Midde KK, et al. 2015. Therapeutic effects of cell-permeant peptides that activate G proteins downstream of growth factors. Proc Natl Acad Sci USA 112: E2602-10.
88. Iiri T, Farfel Z, Bourne HR. 1998. G-protein diseases furnish a model for the turn-on switch. Nature 394: 35-8.
89. Lopez-Sanchez I, Dunkel Y, Roh YS, Mittal Y, et al. 2014. GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis. Nat Commun 5: 4451.
90. Hartung A, Ordelheide AM, Staiger H, Melzer M, et al. 2013. The Akt substrate Girdin is a regulator of insulin signaling in myoblast cells. Biochim Biophys Acta 1833: 2803-11.
91. Ma GS, Lopez-Sanchez I, Aznar N, Kalogriopoulos N, et al. 2015. Activation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity. Mol Biol Cell 26: 4209-23.
92. Tesmer JJ, Berman DM, Gilman AG, Sprang SR. 1997. Structure of RGS4 bound to AlF4-activated G(i alpha1): stabilization of the transition state for GTP hydrolysis. Cell 89: 251-61.
93. Garcia-Marcos M, Kietrsunthorn PS, Wang H, Ghosh P, et al. 2011. G Protein binding sites on Calnuc (nucleobindin 1) and NUCB2 (nucleobindin 2) define a new class of G(alpha) i-regulatory motifs. J Biol Chem 286: 28138-49.
94. Aznar N, Midde KK, Dunkel Y, Lopez-Sanchez I, et al. 2015. Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling. eLife 4: e07091.
95. Johnston CA, Willard FS, Jezyk MR, Fredericks Z, et al. 2005. Structure of Galpha(i1) bound to a GDP-selective peptide provides insight into guanine nucleotide exchange. Structure 13: 1069-80.
96. Johnston CA, Ramer JK, Blaesius R, Fredericks Z, et al. 2005. A bifunctional Galphai/Galphas modulatory peptide that attenuates adenylyl cyclase activity. FEBS Lett 579: 5746-50.
97. Gibb AJ. 2011. Structure and function o 7-TM G-protein coupled receptors. Textbook of Receptor Pharmacology. 3rd Edition. CRC Press, LLC; 79-89.
98. Ghosh P, Garcia-Marcos M, Bornheimer SJ, Farquhar MG. 2008. Activation of Galphai3 triggers cell migration via regulation of GIV. J Cell Biol 182: 381-93.
99. Wang Y, Yuan L, Yang XM, Wei D, et al. 2015. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway. Clin Exp Metastasis 32: 39-53.
100. Lopez-Sanchez I, Kalogriopoulos N, Lo I, Kabir F, et al. 2015. Focal adhesions are foci for tyrosine-based signal transduction via GIV/Girdin and G proteins. Mol Biol Cell 26: 4313-24.
101. Lin C, Ear J, Pavlova Y, Mittal Y, et al. 2011. Tyrosine phosphorylation of the Galpha-interacting protein GIV promotes activation of phosphoinositide 3-kinase during cell migration. Sci Signal 4: ra64.
102. Wang H, Misaki T, Taupin V, Eguchi A, et al. 2015. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin. J Am Soc Nephrol 26: 314-27.
103. Dunkel Y, Ong A, Notani D, Mittal Y, et al. 2012. STAT3 protein up-regulates Galpha-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis. J Biol Chem 287: 41667-83.
104. Mittal Y, Pavlova Y, Garcia-Marcos M, Ghosh P. 2011. Src homology domain 2-containing protein-tyrosine phosphatase-1 (SHP-1) binds and dephosphorylates G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. J Biol Chem 286: 32404-15.
105. Garcia-Marcos M, Ghosh P, Farquhar MG. 2015. GIV/Girdin transmits signals from multiple receptors by triggering trimeric G protein activation. J Biol Chem 290: 6697-704.
106. Mao JZ, Jiang P, Cui SP, Ren YL, et al. 2012. Girdin locates in centrosome and midbody and plays an important role in cell division. Cancer Sci 103: 1780-7.
107. Weng L, Enomoto A, Miyoshi H, Takahashi K, et al. 2014. Regulation of cargo-selective endocytosis by dynamin 2 GTPase-activating protein girdin. EMBO J 33: 2098-112.
108. Lopez-Sanchez I, Ma GS, Pedram S, Kalogriopoulos N, et al. 2015. GIV/girdin binds exocyst subunit-Exo70 and regulates exocytosis of GLUT4 storage vesicles. Biochem Biophys Res Commun 468: 287-93.
109. Ichimiya H, Maeda K, Enomoto A, Weng L, et al. 2015. Girdin/GIV regulates transendothelial permeability by controlling VE-cadherin trafficking through the small GTPase, R-Ras. Biochem Biophys Res Commun 461: 260-7.
110. Enomoto A, Asai N, Namba T, Wang Y, et al. 2009. Roles of disrupted-in-schizophrenia 1-interacting protein girdin in postnatal development of the dentate gyrus. Neuron 63: 774-87.
111. Wang Y, Kaneko N, Asai N, Enomoto A, et al. 2011. Girdin is an intrinsic regulator of neuroblast chain migration in the rostral migratory stream of the postnatal brain. J Neurosci 31: 8109-22.
112. Puseenam A, Yoshioka Y, Nagai R, Hashimoto R, et al. 2009. A novel Drosophila Girdin-like protein is involved in Akt pathway control of cell size. Exp Cell Res 315: 3370-80.
113. Enomoto A, Murakami H, Asai N, Morone N, et al. 2005. Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell 9: 389-402.
114. Jiang P, Enomoto A, Jijiwa M, Kato T, et al. 2008. An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res 68: 1310-8.
115. Wang C, Lin J, Li L, Wang Y. 2014. Expression and clinical significance of girdin in gastric cancer. Mol Clin Oncol 2: 425-8.
116. Natsume A, Kato T, Kinjo S, Enomoto A, et al. 2012. Girdin maintains the stemness of glioblastoma stem cells. Oncogene 31: 2715-24.
117. Zhang YJ, Li AJ, Han Y, Yin L, et al. 2014. Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin. World J Gastroenterol 20: 8229-36.
118. Yamamura Y, Asai N, Enomoto A, Kato T, et al. 2015. Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progression. Cancer Res 75: 813-23.
119. Kitamura T, Asai N, Enomoto A, Maeda K, et al. 2008. Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 10: 329-37.
120. Ito T, Komeima K, Yasuma T, Enomoto A, et al. 2013. Girdin and its phosphorylation dynamically regulate neonatal vascular development and pathological neovascularization in the retina. Am J Pathol 182: 586-96.
121. Miyachi H, Mii S, Enomoto A, Murakumo Y, et al. 2014. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure. J Vasc Surg 60: 479-89e5.
122. Miyake H, Maeda K, Asai N, Shibata R, et al. 2011. The actin-binding protein Girdin and its Akt-mediated phosphorylation regulate neointima formation after vascular injury. Circ Res 108: 1170-9.
123. Miyachi H, Takahashi M, Komori K. 2015. A novel approach against vascular intimal hyperplasia through the suppression of Girdin. Ann Vasc Dis 8: 69-73.
124. Nakai T, Nagai T, Tanaka M, Itoh N, et al. 2014. Girdin phosphorylation is crucial for synaptic plasticity and memory: a potential role in the interaction of BDNF/TrkB/Akt signaling with NMDA receptor. J Neurosci 34: 14995-5008.
125. Blakely BT, Rossi FM, Tillotson B, Palmer M, et al. 2000. Epidermal growth factor receptor dimerization monitored in live cells. Nat Biotechnol 18: 218-22.
126. Chung I, Akita R, Vandlen R, Toomre D, et al. 2010. Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464: 783-7.
127. Schmoll HJ, Van Cutsem E, Stein A, Valentini V, et al. 2012. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 23: 2479-516.